Follow
Marisol Aymerich
Marisol Aymerich
Universidad de Navarra-CIMA
Verified email at unav.es - Homepage
Title
Cited by
Cited by
Year
Two functional epitopes of pigment epithelial–derived factor block angiogenesis and induce differentiation in prostate cancer
S Filleur, K Volz, T Nelius, Y Mirochnik, H Huang, TA Zaichuk, ...
Cancer research 65 (12), 5144-5152, 2005
2142005
Binding of pigment epithelium-derived factor (PEDF) to retinoblastoma cells and cerebellar granule neurons: evidence for a PEDF receptor
E Alberdi, MS Aymerich, SP Becerra
Journal of Biological Chemistry 274 (44), 31605-31612, 1999
2041999
Direct involvement of σ-1 receptors in the dopamine D1 receptor-mediated effects of cocaine
G Navarro, E Moreno, M Aymerich, D Marcellino, PJ McCormick, J Mallol, ...
Proceedings of the National Academy of Sciences 107 (43), 18676-18681, 2010
1852010
Effective GDNF brain delivery using microspheres—a promising strategy for Parkinson's disease
E Garbayo, CN Montero-Menei, E Ansorena, JL Lanciego, MS Aymerich, ...
Journal of Controlled Release 135 (2), 119-126, 2009
1752009
Identification of the neuroprotective molecular region of pigment epithelium-derived factor and its binding sites on motor neurons
MM Bilak, SP Becerra, AM Vincent, BH Moss, MS Aymerich, RW Kuncl
Journal of Neuroscience 22 (21), 9378-9386, 2002
1442002
Expression of the mRNAs encoding for the vesicular glutamate transporters 1 and 2 in the rat thalamus
P Barroso‐Chinea, M Castle, MS Aymerich, M Pérez‐Manso, E Erro, ...
Journal of Comparative Neurology 501 (5), 703-715, 2007
1162007
Thalamic innervation of the direct and indirect basal ganglia pathways in the rat: Ipsi‐and contralateral projections
M Castle, MS Aymerich, C Sanchez‐Escobar, N Gonzalo, JA Obeso, ...
Journal of Comparative Neurology 483 (2), 143-153, 2005
1102005
Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system
MS Aymerich, E Aso, MA Abellanas, RM Tolon, JA Ramos, I Ferrer, ...
Biochemical pharmacology 157, 67-84, 2018
992018
Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells
P Barroso‐Chinea, I Cruz‐Muros, MS Aymerich, M Rodríguez‐Díaz, ...
European Journal of Neuroscience 21 (7), 1815-1827, 2005
972005
Consequences of unilateral nigrostriatal denervation on the thalamostriatal pathway in rats
MS Aymerich, P Barroso‐Chinea, M Pérez‐Manso, AM Munoz‐Patino, ...
European Journal of Neuroscience 23 (8), 2099-2108, 2006
922006
Thalamic innervation of striatal and subthalamic neurons projecting to the rat entopeduncular nucleus
JL Lanciego, N Gonzalo, M Castle, C Sanchez‐Escobar, MS Aymerich, ...
European Journal of Neuroscience 19 (5), 1267-1277, 2004
922004
The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model
D Fernández-Suárez, M Celorrio, JI Riezu-Boj, A Ugarte, R Pacheco, ...
Neurobiology of Aging 35 (11), 2603-2616, 2014
912014
GPR55: A therapeutic target for Parkinson's disease?
M Celorrio, E Rojo-Bustamante, D Fernández-Suárez, E Sáez, ...
Neuropharmacology 125, 319-332, 2017
862017
Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors
G Navarro, MS Aymerich, D Marcellino, A Cortés, V Casadó, J Mallol, ...
Journal of Biological Chemistry 284 (41), 28058-28068, 2009
812009
Structures for G-protein-coupled receptor tetramers in complex with G proteins
A Cordomí, G Navarro, MS Aymerich, R Franco
Trends in biochemical sciences 40 (10), 548-551, 2015
712015
Gut microbial dysbiosis after traumatic brain injury modulates the immune response and impairs neurogenesis
M Celorrio, MA Abellanas, J Rhodes, V Goodwin, J Moritz, S Vadivelu, ...
Acta Neuropathologica Communications 9 (1), 1-22, 2021
652021
Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease
D Elgueta, MS Aymerich, F Contreras, A Montoya, M Celorrio, ...
Neuropharmacology 113, 110-123, 2017
652017
Sustained release of bioactive glycosylated glial cell-line derived neurotrophic factor from biodegradable polymeric microspheres
E Garbayo, E Ansorena, JL Lanciego, MS Aymerich, MJ Blanco-Prieto
European journal of pharmaceutics and biopharmaceutics 69 (3), 844-851, 2008
642008
Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson’s disease
M Celorrio, D Fernández-Suárez, E Rojo-Bustamante, V Echeverry-Alzate, ...
Brain, Behavior, and Immunity 57, 94-105, 2016
632016
GPR40 activation leads to CREB and ERK phosphorylation in primary cultures of neurons from the mouse CNS and in human neuroblastoma cells
M Zamarbide, I Etayo‐Labiano, A Ricobaraza, E Martínez‐Pinilla, ...
Hippocampus 24 (7), 733-739, 2014
612014
The system can't perform the operation now. Try again later.
Articles 1–20